Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Avoidance of dual publication. Statement by the Council of Biology Editors. 1973 Am. J. Obstet. Gynecol. pmid:4681830
Bruce JD et al. Lactation and intra-mammary pressure in rats bearing oestrogen, progesterone or norethindrone mammary implants; effects of oxytocin. 1973 Acta Endocrinol. pmid:4800352
Rozenbaum H [Advantage of low-dose oral contraception]. 1973 Contracept Fertil Sex (Paris) pmid:12276840
Daane TA et al. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats. 1973 Am. J. Obstet. Gynecol. pmid:4729733
Briggs MH Steroid hormones and the fertilizing capacity of spermatozoa. 1973 Steroids pmid:4127001
Meglioli G et al. Effects of progestogenic substances on the uterine secretion of spayed rats primed with oestradiol. 1973 Horm. Res. pmid:4127110
Meglioli G and Desaulles PA Modifications induced by progestogen treatment in the action of rat uterine secretion on corona cells in vitro. 1973 Horm. Res. pmid:4127850
Gozan KB [Influence of synthetic estro-progestatives on the percentage of some inorganic molecules (Ca, Mg) in the tissues of the female rat]. 1973 C. R. Seances Soc. Biol. Fil. pmid:4785085
Holt R Laparoscopic removal of an intrauterine contraceptive device in an oral contraceptive user. 1973 South. Med. J. pmid:4270142
Garmendia F et al. Serum LH concentration in women under contraceptive treatment with estrogen-free progestagens. 1973 Horm. Metab. Res. pmid:4707699
Stoll BA Hormonal therapy of gynecologic malignancy. 1973 Clin Obstet Gynecol pmid:4593949
Kucera J [Congenital defects due to drugs]. 1973 Cesk Pediatr pmid:4594858
Moghissi KS et al. Contraceptive mechanism of microdose norethindrone. 1973 Obstet Gynecol pmid:4735314
Freudenthal RI et al. Metabolism and distribution of norethynodrel in pregnant and nonpregnant mice. 1973 Toxicol. Appl. Pharmacol. pmid:4686779
Schillinger E and Gerhards E Influence of hormonal contraceptives on carbohydrate and lipid metabolism in the rat. 1973 Biochem. Pharmacol. pmid:4722455
Kopecný J and Kopecná V [Cytological check-up on the effectiveness of the hormonal treatment of endometriosis]. 1973 Cesk Gynekol pmid:4729366
Whyte JC and Pooransingh CS Low dosage progestagen as an oral contraceptive: a clinical study. 1973 Can Med Assoc J pmid:4730201
Roxburgh DR and West MJ The use of norethisterone to suppress menstruation in the intellectually severely retarded woman. 1973 Med. J. Aust. pmid:4746398
Spellacy WN et al. Metabolic studies in women taking norethindrone for 6 months' time (measurements of blood glucose, insulin, and triglyceride concentrations). 1973 Fertil. Steril. pmid:4710007
Norethindrone--the "minipill". 1973 Med Lett Drugs Ther pmid:4712978
Fairburn B Intracranial venous thrombosis complicating oral contraception: treatment by anticoagulant drugs. 1973 Br Med J pmid:4714850
Gorfinkel HJ and O'Driscoll RG Control of paroxysmal ventricular tachycardia with oral contraceptives. 1973 Chest pmid:4725090
Jover Sanz E and Velasco Alonso R [Action of synthetic progestational drugs on plasma lipids]. 1973 Rev Clin Esp pmid:4751039
Kerl H et al. [Treatment of "collagen and autoimmune" diseases (author's transl)]. 1973 Wien. Klin. Wochenschr. pmid:4757177
Edelstyn GA Norethisterone acetate (SH420) in advanced breast cancer. 1973 Cancer pmid:4757921
Edelstyn GA and Macrae KD Cyclical combination chemotherapy in advanced breast cancer. 1973 Br. J. Cancer pmid:4758373
Reed MJ et al. Localization of norethisterone in the reproductive tract of women. 1973 J. Endocrinol. pmid:4761686
Dvorák K and Cernoch A [Norsteroids in gynaecological therapy (author's transl)]. 1973 Cesk Gynekol pmid:4765141
Ylöstalo P and Vuopala S Contraceptive treatment with low doses of gestagen in cases with medical history of hepatosis of pregnancy. 1973 Acta Obstet Gynecol Scand pmid:4743776
Johnson GK et al. Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. 1973 Am J Dig Dis pmid:4688570
Wardekar AS et al. Myocardial infarction and oral contraceptives. 1973 South. Med. J. pmid:4691020
Davidson MB and Holzman GB Role of growth hormone in the alteration of carbohydrate metabolism induced by oral contraceptive agents. 1973 J. Clin. Endocrinol. Metab. pmid:4683182
Corriere JN Pathologic changes in the human urinary tract due to anovulatory drug administration. 1973 J Surg Oncol pmid:4703842
Barbosa J et al. Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens. 1973 J. Clin. Endocrinol. Metab. pmid:4119677
Baker BL et al. Direct action of synthetic progestins on the hypophysis. 1973 Endocrinology pmid:4686326
Briggs M and Briggs M Effects of some contraceptive steroids on serum proteins of women. 1973 Biochem. Pharmacol. pmid:4733678
Arora P Silastic implant: a new method for birth control. 1973 Nurs J India pmid:4493439
Radnót M and Follmann P Ocular side-effects of oral contraceptives. 1973 Ann. Clin. Res. pmid:4206444
Pelzmann KS Absorption of chlormadinone acetate and norethindrone from in situ rat gut. 1973 J Pharm Sci pmid:4127437
McLeroy VJ and Schendel HE Influence of oral contraceptives on ascorbic acid concentrations in healthy, sexually mature women. 1973 Am. J. Clin. Nutr. pmid:4122161
Beckerhoff R et al. Plasma-aldosterone during oral-contraceptive therapy. 1973 Lancet pmid:4122566
Hempel E et al. [Enzyme induction by drugs and hormonal contraception]. 1973 Zentralbl Gynakol pmid:4129505
Davidoff F et al. Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy. 1973 N. Engl. J. Med. pmid:4723103
Rose DP and Toseland PA Urinary excretion of quinolinic acid and other tryptophan metabolites after deoxypyridoxine or oral contraceptive administration. 1973 Metab. Clin. Exp. pmid:4683526
Brogden RN et al. Progestagen-only oral contraceptives: a preliminary report of the action and clinical use of norgestrel and norethisterone. 1973 Drugs pmid:4130566
Tenhaeff D [Proceedings: Hormone excretion and cyclus course in various low dosage progestational hormones]. 1973 Arch Gynakol pmid:4130936
Biggs JS Hair growth in a patient with hirsutism: poor response to ovarian suppression. 1973 Aust N Z J Obstet Gynaecol pmid:4532547
Maeyama M et al. Conversion of 20 alpha-hydroxy-4-pregnen-3-one to progesterone by human endometrium in vitro. 1973 J. Steroid Biochem. pmid:4131400
Lunell NO et al. The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D- hydroxybutyrate and triglycerides. 1973 Acta Obstet Gynecol Scand pmid:4688539
Jones RC and Edgren RA The effects of various steroids on the vaginal histology in the rat. 1973 Fertil. Steril. pmid:4694503
Kissebah AH et al. Mechanism of hypertriglyceridaemia associated with contraceptive steroids. 1973 Horm. Metab. Res. pmid:4351691
Galletti F and Gardi R Effect of ovarian hormones and synthetic progestins on vaginal sialic acid in the rat. 1973 J. Endocrinol. pmid:4706599
Banerjee RC et al. Effects of norethindrone (17-ethynyl-17 -hydroxy-4-estren-3-one) and norgestrel (dl-13 -ethyl-17-ethynyl-17 -hydroxy-4-gonen-3-one) on the tissue distribution of 3 H-estradiol-17 in ovariectomized rats. 1973 Steroids pmid:4687305
Zussman L The climacteric. 1973 Proc. R. Soc. Med. pmid:4351701
Anglade JP [Norethisterone acetate and endometriosis. Clinical study apropos of 10 cases]. 1972 Sep-Oct Therapie pmid:4651404
Anglade JP [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes]. 1972 Sep-Oct Therapie pmid:4675625
Pomerance J Steroid contraception and its effects on lactation are a public health dilemma. 1972 Aug-Sep Health Serv Rep pmid:4120091
[Can the mini-pills be taken cyclically?]. 1972 Tidsskr. Nor. Laegeforen. pmid:4649638
el-Mahgoub S and Karim M The long-term use of injectable norethisterone enanthate as a contraceptive. 1972 Contraception pmid:4650643
Boris A et al. The effects of some progestational steroids on pubertal ovulation in the rat. 1972 Contraception pmid:4650647
el-Mahgoub S and Ammar R Ovarian changes during progestogen amenorrhoea. 1972 J Obstet Gynaecol Br Commonw pmid:4651295
Tinsley FC and Brennan DM Antifertility effects of progestins in hamsters. 1972 Fertil. Steril. pmid:4118864
Poller L The effects of progestogens on blood clotting and platelet function. 1972 J. Clin. Pathol. pmid:4119307
Yokoyama Y Influences of gestagen upon carcinoma in situ of the cervix (a histologic study). 1972 Acta Obstet Gynaecol Jpn pmid:4119434
Müller R et al. [Comparative studies on endometrial behavior under the effect of various contraceptives]. 1972 Zentralbl Gynakol pmid:4119793
Chandra RK Serum levels of IgG and -macroglobulin and incidence of cryofibrinogenaemia in women taking oral contraceptives. 1972 J. Reprod. Fertil. pmid:4622500
Tenhaeff D et al. [Contraception with two low-dosage mestranol-norethisterone combinations]. 1972 Fortschr. Med. pmid:4641330
Cochrane P and Weatherall DJ The variation of neutrophil alkaline phosphatase during the menstrual cycle. 1972 J Obstet Gynaecol Br Commonw pmid:4642375
Larsson-Cohn U et al. Concentration of antithrombin 3 during combined and progestogen-only oral contraceptive treatment. 1972 Acta Obstet Gynecol Scand pmid:4642717
Ng KH and Lee KH Inhibition of postpartum lactation with single-dose drugs. 1972 Aust N Z J Obstet Gynaecol pmid:4502478
Schenker JG et al. The effect of oral contraceptives on microcirculation. 1972 Obstet Gynecol pmid:5049908
Bagdade JD Therapy of the hyperlipoproteinemias. 1972 Acta Diabetol Lat pmid:4605376
Zacherle BJ and Richardson JA Irreversible renal failure secondary to hypertension induced by oral contraceptives. 1972 Ann. Intern. Med. pmid:4559540
Kenyon IE Unplanned pregnancy in an epileptic. 1972 Br Med J pmid:5015305
Rose DP and Adams PW Oral contraceptives and tryptophan metabolism: effects of oestrogen in low dose combined with a progestagen and of a low-dose progestagen (megestrol acetate) given alone. 1972 J. Clin. Pathol. pmid:5018716
Stephens ME et al. Oral contraceptives and folate metabolism. 1972 Clin Sci pmid:5020281
Martin PL et al. Oral menopausal therapy using 17- micronized estradiol. A preliminary study of effectiveness, tolerance and patient preference. 1972 Obstet Gynecol pmid:5023261
Gustafson A and Svanborg A Gonadal steroid effects on plasma lipoproteins and individual phospholipids. 1972 J. Clin. Endocrinol. Metab. pmid:4342037
Kohorn EI et al. The relation of the structure of progestational steroids to nucleolar differentiation in human endometrium. 1972 J Clin Endocrinol pmid:12256658
Wilensky RJ and Hubbard TB Thrombosis of the digital vessels secondary to oral contraceptives. 1972 Am. J. Obstet. Gynecol. pmid:4635186
Starup J Amenorrhoea following oral contraception. 1972 Acta Obstet Gynecol Scand pmid:4642722
Osman MM et al. The effect of an oral contraceptive on serum lipids. 1972 Contraception pmid:4346646
Besterman EM and Gillett MP Altered plasma-lysolecithin levels and platelets. 1972 Lancet pmid:4108996
Maqueo M et al. Ovarian morphologyy after prolonged use of steroid contraceptive agents. 1972 Contraception pmid:4119577
Johnson AL Aliphatic esters of 6,6-difluoro-17 -hydroxy-17-ethynyl-4-estren-3-one (6,6-difluoronorethindrone) and (+)-6,6-difluoro-13 -ethyl-17 -hydroxy-17-ethynyl-4-gonen-3-one ((+)-6,6-difluoronorgestrel). 1972 Steroids pmid:5073576
Kishimoto Y et al. Metabolism of oral contraceptives. I. Metabolism of ethynodiol diacetate in women. 1972 Xenobiotica pmid:5076570
Hamner CE and Wilson LA Inhibition of capacitation in the rabbit. 1972 Fertil. Steril. pmid:4110310
Cook CE et al. Norethynodrel metabolites in human plasma and urine. 1972 J. Pharmacol. Exp. Ther. pmid:5080031
Kharma K et al. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. 1972 Am. J. Obstet. Gynecol. pmid:4110418
Stillwell WG et al. Characterization of metabolites of steroid contraceptives by gas chromatography and mass spectrometry. 1972 J. Steroid Biochem. pmid:5085379
Rivers JM and Devine MM Plasma ascorbic acid concentrations and oral contraceptives. 1972 Am. J. Clin. Nutr. pmid:5035056
Johnson AL 17 -Propadienyl, 17 -propynyl, and 17 -trifluoropropynyl analogs of 6,6-difluoronorethindrone. 1972 J. Med. Chem. pmid:5044304
Yamazaki I and Nakayama R Comparison of ovulation-inducing effect between estrogen and progestin in the ovulation-blocked rat by chlorpromazine. 1972 Endocrinol. Jpn. pmid:4341647
Preston SN A report of a collaborative dose-response clinical study using decreasing doses of combination oral contraceptives. 1972 Contraception pmid:4659582
Nygren KG et al. Postovulatory contraception in women with large doses of norethindrone. 1972 Contraception pmid:4650660
Beck RP et al. Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol. 1972 Am. J. Obstet. Gynecol. pmid:5060381
Levine LS et al. Androgen production in boys with sexual precocity and congenital adrenal hyperplasia. 1972 Metab. Clin. Exp. pmid:4335735
Lawson JP and Bradshaw FR Experience with norethisterone 0.35 mg. as an oral contraceptive--a preliminary report. 1972 Curr Med Res Opin pmid:4668861
Larsson-Cohn U et al. Effects of continuous daily administration of 0.1 mg of norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. 1972 Acta Endocrinol. pmid:4678199
Rifkin I et al. Amenorrhea following use of oral contraceptives. 1972 Am. J. Obstet. Gynecol. pmid:4678381